Skip to main content
Clinical Trials/NCT05654766
NCT05654766
Not yet recruiting
Not Applicable

Development of a Method for Assessing the Functional Activity of Platelets for the Differential Diagnosis of Thrombocytopathies Using Flow Cytometry

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Immune Thrombocytopenia
Sponsor
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
Enrollment
200
Primary Endpoint
Expression of CD41 by platelets
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

The purpose of this study is to develop a highly sensitive method for assessing the functional activity of platelets for use in the differential diagnosis of thrombocytopenia and platelet defects.

Detailed Description

The purpose of this study is to develop a highly sensitive method for assessing the functional activity of platelets using flow cytometry and turbidimetric and impedance aggregometry for use in the differential diagnosis of thrombocytopenia and platelet defects

Registry
clinicaltrials.gov
Start Date
January 2, 2023
End Date
December 31, 2024
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Pediatric participants with hemorrhagic syndrome (hemorrhagic rash, bruising, bleeding, increased bleeding of the skin and mucous membranes, spontaneous hemorrhages in soft tissues and joints)
  • Pediatric participants with acute leukemia
  • Parameters of the plasma level of blood coagulation correspond to the age normal levels

Exclusion Criteria

  • Anticoagulation drug therapy
  • Antiaggregation drug therapy
  • Biologically active additives

Outcomes

Primary Outcomes

Expression of CD41 by platelets

Time Frame: baseline

Assessment of platelet functional activity by the detection of CD41

Impedance of platelet aggregates

Time Frame: baseline

Assessment of platelet functional activity by impedance aggregometry

Fibrinogen level

Time Frame: baseline

Assessment of blood coagulation using Fibrinogen level test

Expression of CD42b by platelets

Time Frame: baseline

Assessment of platelet functional activity by the detection of CD42b

Expression of CD62p by platelets

Time Frame: baseline

Assessment of platelet functional activity by the detection of CD62p

Level of platelet aggregation

Time Frame: baseline

Assessment of platelet functional activity by turbidimetric aggregometry

Expression of Annexin V by platelets

Time Frame: baseline

Assessment of platelet functional activity by the detection of Annexin V

aPTT

Time Frame: baseline

Assessment of blood coagulation using aPTT

Expression of PAC-1 by platelets

Time Frame: baseline

Assessment of platelet functional activity by the detection of PAC-1

Expression of CD63 by platelets

Time Frame: baseline

Assessment of platelet functional activity by the detection of CD63

Prothrombin test

Time Frame: baseline

Assessment of blood coagulation using Prothrombin test

Thrombin time

Time Frame: baseline

Assessment of blood coagulation using Thrombin time test

Similar Trials